These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2341257)

  • 21. [Organization of the nuclear medicine department].
    Martinenghi C
    Minerva Med; 1970 Oct; 61(80):4430-46. PubMed ID: 5481345
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiation dose calculations in persons receiving injection of samarium-153 EDTMP.
    Logan KW; Volkert WA; Holmes RA
    J Nucl Med; 1987 Apr; 28(4):505-9. PubMed ID: 3572536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid discharges from the use of radionuclides in medicine (diagnosis).
    Barquero R; Agulla MM; Ruiz A
    J Environ Radioact; 2008 Oct; 99(10):1535-8. PubMed ID: 18243441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic reference values in nuclear medicine recommendations of the Radiation Safety Commission. Discharged at the 167th meeting of the Radiation Safety Commission July 6-7 2000].
    Schicha H;
    Nuklearmedizin; 2000 Dec; 39(8):N118-9. PubMed ID: 11189904
    [No Abstract]   [Full Text] [Related]  

  • 25. Calculations of dose, population dose and health effects due to boiling water nuclear power reactor radionuclide emissions in the United States during 1971.
    Martin JA; Nelson CB
    Radiat Data Rep; 1974 Jun; 15(6):309-19. PubMed ID: 4407901
    [No Abstract]   [Full Text] [Related]  

  • 26. What is nuclear medicine?
    Savage J
    Australas Nurses J; 1978 Dec; 8(4):19-21. PubMed ID: 106823
    [No Abstract]   [Full Text] [Related]  

  • 27. Task-specific monitoring of nuclear medicine technologists' radiation exposure.
    Smart R
    Radiat Prot Dosimetry; 2004; 109(3):201-9. PubMed ID: 15254324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of thermoluminescent dosimeters for measurement of dose to the hands of nuclear medicine technicians.
    Anderson DW; Richter CW; Ficken VJ; Adams GD
    J Nucl Med; 1972 Aug; 13(8):627-9. PubMed ID: 5041640
    [No Abstract]   [Full Text] [Related]  

  • 29. The production of no-carrier-added radiopharmaceuticals with special reference to radionuclide impurities.
    Lagunas-Solar MC
    Int J Nucl Med Biol; 1983; 10(2-3):75-84. PubMed ID: 6642897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing a threshold for 131I bioassay in nuclear medicine personnel.
    Liang Y; Chu RY; Galbraith WK; Macdurmon GW; Sonnad JR
    Health Phys; 2008 Nov; 95(5 Suppl):S175-9. PubMed ID: 18849711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of alanine for dosimetry intercomparisons among Italian radiotherapy centers.
    De Angelis C; De Coste V; Fattibene P; Onori S; Petetti E
    Appl Radiat Isot; 2005 Feb; 62(2):261-5. PubMed ID: 15607459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radiation protection in nuclear medicine--a look back].
    Feine U
    Strahlenschutz Forsch Prax; 1985; 26():122-30. PubMed ID: 4089896
    [No Abstract]   [Full Text] [Related]  

  • 33. The importance and required detection levels of radionuclide impurities--a medical physicist's view.
    Haggith JW
    Int J Nucl Med Biol; 1983; 10(2-3):85-9. PubMed ID: 6417037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there life in MARS?
    Nucl Med Commun; 2007 May; 28(5):425-6. PubMed ID: 17414895
    [No Abstract]   [Full Text] [Related]  

  • 35. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
    Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
    Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Institute of Medicine. Panel to Feds: hands off radioisotopes.
    Wolfgang L
    Science; 1995 Dec; 270(5244):1918. PubMed ID: 8533079
    [No Abstract]   [Full Text] [Related]  

  • 37. An approximate relation for the prediction of the dose rate from radioactivity induced in high energy particle accelerators.
    Sullivan AH
    Health Phys; 1972 Aug; 23(2):253-5. PubMed ID: 4644596
    [No Abstract]   [Full Text] [Related]  

  • 38. Dose to the patient due to medical diagnostic use of radionuclides.
    Trott NG
    J Belge Radiol; 1977; 60(6):449-61. PubMed ID: 612669
    [No Abstract]   [Full Text] [Related]  

  • 39. Radionuclide metrology in the life sciences seminar. The International Committee for Radionuclide Metrology, Paris, 6-8 September 1982.
    Int J Nucl Med Biol; 1983; 10(2-3):65-171. PubMed ID: 6642894
    [No Abstract]   [Full Text] [Related]  

  • 40. The safe tracer dose in medical investigation.
    Saenger EL; Kereiakes JG
    Prog At Med; 1971; 3():139-65. PubMed ID: 4946936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.